Navigation Links
Avazzia and ChiroCode Institute Jointly Market Advanced Technology for Relief of Chronic Pain
Date:1/8/2010

PHOENIX and DALLAS, Jan. 8 /PRNewswire/ -- ChiroCode Institute and Avazzia will jointly promote advanced technology devices that help chiropractors and other caregivers manage their patients' chronic pain. The Avazzia BEST Pro Sport device combines microcurrent transcutaneous stimulation with somatic bio-feedback to provide improved results while making obsolete existing TENS devices. Benefits for patients include:

  • Convenient, easy to use
  • Relief for chronic and intractable pain
  • Non-pharmaceutical relief with no drug side effects
  • Reimbursement available from Medicare and most private insurance

Provider benefits include:

  • Biofeedback interacts with body's responses to stimulus for more effective therapy
  • Adjunctive treatment in the management of post-surgical and post-traumatic pain
  • Optional accessories enable better area coverage and delivery of electro-stimulation therapy

Lamont Leavitt, CEO of ChiroCode Institute, Phoenix, AZ, said: "Avazzia is exactly the kind of talented, fast-moving company my father was searching for in order to form a marketing partnership. We feel Avazzia products fill a niche that was not previously served in terms of cost, performance, and product mix. Working together will help us realize our long-term goal of helping people."

Tim Smith, CEO of Avazzia, Dallas, TX, said: "Entering any market can be fraught with difficulty. Teaming with ChiroCode gives us a strong advantage in speed of penetration and will help lower our costs by decreasing our time-to-market. With our company's semiconductor and manufacturing expertise, and ChiroCode's deep roots formed by serving doctors, we anticipate an exciting and profitable market entry."

According to Smith, "The B.E.S.T technology on which Avazzia products are based is unique in its approach to pain management. Microcurrent stimulation is a proven technology for control of pain, but earlier generations of products have not had this product's reliability. And the ability of Avazzia B.E.S.T products to "listen" to the patients' response and adjust dosing accordingly, simplifies the application. The leading cause of lost productivity and decreased enjoyment of life is usually pain. Avazzia has won FDA and European approvals for the treatment of pain. It is a wonderful adjunct to professional therapy because it meets a 21st century need with current space-age technology."

SEE THE AVAZZIA BEST PRO SPORT AT THE PARKER SEMINAR, LAS VEGAS, NV, Jan 14-16, 2010

www.chirocode.com

www.avazzia.com

SOURCE ChiroCode Institute

RELATED LINKS
http://www.chirocode.com
http://www.avazzia.com

'/>"/>

SOURCE ChiroCode Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.
2. ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods
3. SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology
4. Van Andel Institute Cuts Ribbon on $178 Million Expansion
5. Laser Spine Institute Partners with United Healthcare
6. Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace
7. ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
8. Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool
9. Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
10. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
11. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Summary ... disease pipeline guide Primary Hyperoxaluria - Pipeline Review, ... Hyperoxaluria (Genito Urinary System And Sex Hormones) pipeline ... characterized by recurrent kidney and bladder stones. It ... oxalate. Symptoms include blood in the urine, pain ...
(Date:3/23/2017)... , March 23, 2017  Digital Pharmacist ... ), a rapidly growing digital health company, ... mobile app that allows patients to manage their ... locations such as Denver Health Pharmacy, USave Pharmacy ... acquisition helps Digital Pharmacist accelerate its product development ...
(Date:3/23/2017)...  Ethicon* today announced the completion of its ... medical device company that manufactures and markets the ... of Gastroesophageal Reflux Disease (GERD). This acquisition is ... of minimally invasive options for patients suffering from ... the transaction have not been disclosed. ...
Breaking Medicine Technology:
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... investment in Los Angeles based healthcare technology company California Healthcom Group (CHG). ... the US, and healthcare arena. With headquarters in California, CHG is a growing, ...
(Date:3/23/2017)... Scottsdale, AZ (PRWEB) , ... March 23, 2017 , ... ... helping people around the world to manage stress and anxiety. , “Buzzies change ... Serin, neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... new solution that enables organizations to easily reprint customer invoices, bills, statements and ... automates all of the steps needed to retrieve and print the documents and ...
(Date:3/23/2017)... CA (PRWEB) , ... March 23, 2017 , ... ... management and workflow solutions, today named The Resource Group as their 2016 Microsoft ... and partner conference in Newport Beach, CA. The award recognizes The Resource ...
(Date:3/23/2017)... ... 2017 , ... ChenMed, a privately owned medical, management and ... executive team expansion needed to further optimize growth and performance. , “We are ... Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and Donald Trexler round-out ...
Breaking Medicine News(10 mins):